AI assistant
Elevance Health, Inc. — Director's Dealing 2012
May 18, 2012
29933_dirs_2012-05-18_ab67b1c3-9a88-40c2-8429-05af3a34fe74.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WELLPOINT, INC (WLP)
CIK: 0001156039
Period of Report: 2012-05-16
Reporting Person: BURKE SHEILA P (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-16 | Phantom Stock Units | $ | A | 2681 | Acquired | Common Stock (2681) | Direct |
Footnotes
F1: The phantom stock units were accrued under the WellPoint, Inc. ("Company") Board of Directors Deferred Compensation Plan ("the "Plan").
F2: The Conversion or Exercise Price of the Derivative Security is 1-for-1.
F3: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Plan in accordance with the terms of the Plan.